Precision Medicine Transforms Gynecologic Cancer Care
Received Date: Apr 01, 2025 / Published Date: Apr 29, 2025
Abstract
Significant advancements are transforming gynecologic cancer care, moving beyond traditional methods. Precision medicine, targeted agents like PARP inhibitors, and emerging immunotherapies are improving outcomes for ovarian, cervical, and endome trial cancers. Molecular classification guides treatment decisions, while Human Papillomavirus (HPV)-based screening and novel biomarkers enhance early detection. Efforts also focus on managing rarer malignancies like vulvar cancer and uterine Leiomyosar coma, where new systemic therapies offer hope. These innovations reflect a profound shift towards personalized and more effective patient management strategies.
Citation: Ortiz LM (2025) Precision Medicine Transforms Gynecologic Cancer Care. Current Trends Gynecol Oncol 10: 267.
Copyright: 漏 2025 Laura M. Ortiz This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted聽use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 565
- [From(publication date): 0-0 - Apr 05, 2026]
- Breakdown by view type
- HTML page views: 454
- PDF downloads: 111
